Pharma Industry Insights
Insights from global industry leaders on the trends shaping the future of life sciences and beyond
Chaozhong Zou
Executive Director and General Manager/Professor, Cincinnati Children's
In vivo CAR-T therapies are gaining momentum, with early clinical data showing encouraging efficacy
Read More →
Nicola Redfern
Independent Consultant in C> Arena
Cell and gene therapies represent one of the most promising frontiers in modern medicine, with the potential to significantly improve quality
Read More →
Lee Buckler
Managing Director, Cell Therapy Group
The cell and gene therapy sector is reaching a pivotal maturation point in 2026, with several regulatory approvals already pending in the United States
Read More →
Eugene Boland
Vice President of Quality, Longeveron
2026 may remain a turbulent period for cell and gene therapy companies approaching BLA submissions, particularly those developing treatment
Read More →
Benjamin McLeod
Founder, Convey Bio
One of the most important developments to watch over the next 12–18 months in cell and gene therapy is the evolving regulatory
Read More →
Dr. Takis Athanasopoulos
CEO & Founder, Gene & Cell Ltd
With more than 25 years in the cell and gene therapy sector—from academic research to leadership roles in Big Pharma, biotech
Read More →
